Banacep Vet 5 mg Film-Coated Tablet for Dogs and Cats Benazepril Hydrochloride

Main information

  • Trade name:
  • Banacep Vet 5 mg Film-Coated Tablet for Dogs and Cats Benazepril Hydrochloride
  • Available from:
  • Laboratorios Calier, SA
  • Prescription type:
  • POM-V
  • Medicine type:
  • Veterinary

Localization

  • Available in:
  • United Kingdom
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Cats, Dogs

Status

  • Source:
  • VMD
  • Authorization date:
  • 2008-02-12

Documents

9-12-2015

Orphan designation: Imatinib mesilate, for the: Treatment of myelodysplastic / myeloproliferative diseases

On 23 December 2005, orphan designation (EU/3/05/340) was granted by the European Commission Novartis Europharm Limited, United Kingdom, for imatinib mesilate for the treatment of myelodysplastic / myeloproliferative diseases. Please note that this product was withdrawn from the Community Register of designated orphan medicinal products in April 2012 on request of the sponsor.

Europe - EMA - European Medicines Agency

28-7-2015

Conclusion on the peer review of the pesticide risk assessment of the active substance thifensulfuron-methyl

European Food Safety Authority The conclusions of the European Food Safety Authority (EFSA) following the peer review of the initial risk assessments carried out by the competent authority of the rapporteur Member State the United Kingdom, for the pesticide active substance thifensulfuron-methyl are reported.  The context of the peer review was that required by Commission Regulation (EU) No 1141/2010 as amended by Commission Implementing Regulation (EU) No 380/2013. The conclusions were reach...

Europe - EFSA - European Food Safety Authority EFSA Journal

28-7-2015

Scientific Opinion on Flavouring Group Evaluation 208 Revision 1 (FGE.208Rev1): Consideration of genotoxicity data on representatives for 10 alicyclic aldehydes with the α,β-unsaturation in ring / side-chain and precursors from chemical subgroup 2.2 of

EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) The EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids was requested to evaluate the genotoxic potential of flavouring substances from subgroup 2.2 of FGE.19 in the Flavouring Group Evaluation 208 Revision 1 (FGE.208Rev1). The Flavour Industry has provided additional genotoxicity studies on p-mentha-1,8-dien-7-al [FL-no: 05.117], the representative substance for FGE.19 subgroup 2.2. T...

Europe - EFSA - European Food Safety Authority EFSA Journal

28-7-2015

Modification of the existing maximum residue levels for fenoxycarb in peaches and olives

European Food Safety Authority In accordance with Article 6 of Regulation (EC) No 396/2005, the evaluating Member State (EMS), France, received an application from Syngenta Agro S.A.S. to modify the existing maximum residue levels (MRLs) for the active substance fenoxycarb in peaches and olives. In order to accommodate for the intended uses of fenoxycarb, France proposed to raise the value of the existing MRL of 1 mg/kg (both peaches and olives) to 1.5 mg/kg in peaches and 3.0 mg/k...

Europe - EFSA - European Food Safety Authority EFSA Journal

28-7-2015

Reasoned opinion on the review of the existing maximum residue levels (MRLs) for acrinathrin according to Article 12 of Regulation (EC) No 396/2005

European Food Safety Authority According to Article 12 of Regulation (EC) No 396/2005, the European Food Safety Authority (EFSA) has reviewed the Maximum Residue Levels (MRLs) currently established at European level for the pesticide active substance acrinathrin. In order to assess the occurrence of acrinathrin residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Regulation (EC) No 1107/2009 as well as the Europe...

Europe - EFSA - European Food Safety Authority EFSA Journal

27-7-2015

Orphan designation: Obinutuzumab, for the: Treatment of marginal zone lymphoma

Europe - EMA - European Medicines Agency

27-7-2015

Orphan designation: Obinutuzumab, for the: Treatment of follicular lymphoma

Europe - EMA - European Medicines Agency

27-7-2015

Orphan designation: Trehalose, for the: Treatment of spinocerebellar ataxia

Europe - EMA - European Medicines Agency

27-7-2015

Unauthorized natural health product “Remogen” containing ibogaineand the risk of abnormal heart rhythms

OTTAWA – Health Canada is advising Canadians that it has received a serious domestic adverse reaction report of abnormal heart rhythms associated with the ingestion of “Remogen” (containing ibogaine), an unauthorized natural health product in Canada that may pose serious health risks. Canadians who have used this product and have concerns about their health should speak with their healthcare practitioner.

Canada - Health Canada

27-7-2015

News and press releases: Fast track routes for medicines that address unmet medical needs

Launch of two-month public consultations on revised guidelines on accelerated assessment and conditional marketing authorisation

Europe - EMA - European Medicines Agency

27-7-2015

DESMOPRESSIN ACETATE Tablet [American Health Packaging]

Updated Date: Jul 27, 2015 EST

US - DailyMed

27-7-2015

BENAZEPRIL HYDROCHLORIDE Tablet, Film Coated [Eon Labs, Inc.]

Updated Date: Jul 27, 2015 EST

US - DailyMed

27-7-2015

DIPHENHYDRAMINE HYDROCHLORIDE Injection [REMEDYREPACK INC. ]

Updated Date: Jul 27, 2015 EST

US - DailyMed

27-7-2015

CEFTRIAXONE AND DEXTROSE (Ceftriaxone) Injection, Solution [B. Braun Medical Inc.]

Updated Date: Jul 27, 2015 EST

US - DailyMed

27-7-2015

GLIPIZIDE Tablet [Sun Pharmaceutical Industries, Inc.]

Updated Date: Jul 27, 2015 EST

US - DailyMed

27-7-2015

IBUPROFEN Tablet [MARKSANS PHARMA LIMITED]

Updated Date: Jul 27, 2015 EST

US - DailyMed

27-7-2015

TRAMADOL HYDROCHLORIDE Capsule, Extended Release [Medsource Pharmaceuticals]

Updated Date: Jul 27, 2015 EST

US - DailyMed

27-7-2015

ESZOPICLONE Tablet, Film Coated [Medsource Pharmaceuticals]

Updated Date: Jul 27, 2015 EST

US - DailyMed

27-7-2015

OXYCODONE AND ACETAMINOPHEN Tablet [Medsource Pharmaceuticals]

Updated Date: Jul 27, 2015 EST

US - DailyMed

27-7-2015

ARIPIPRAZOLE Tablet [Apotex Corp]

Updated Date: Jul 27, 2015 EST

US - DailyMed

27-7-2015

NALBUPHINE HYDROCHLORIDE Injection, Solution [Hospira, Inc.]

Updated Date: Jul 27, 2015 EST

US - DailyMed

27-7-2015

LOPID (Gemfibrozil) Tablet, Film Coated [Parke-Davis Div Of Pfizer Inc]

Updated Date: Jul 27, 2015 EST

US - DailyMed

27-7-2015

ALIVIO (Ibuprofen) Tablet [Alivio Medical Products, LLC]

Updated Date: Jul 27, 2015 EST

US - DailyMed

27-7-2015

PFIZERPEN (Penicillin G Potassium) Powder, For Solution [Roerig]

Updated Date: Jul 27, 2015 EST

US - DailyMed

24-7-2015

News and press releases: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2015

Ten new medicines recommended for authorisation in the EU, and first malaria vaccine receives positive scientific opinion for use outside the EU

Europe - EMA - European Medicines Agency

24-7-2015

News and press releases: First malaria vaccine receives positive scientific opinion from EMA

Mosquirix to be used for vaccination of young children, together with established antimalarial interventions

Europe - EMA - European Medicines Agency

24-7-2015

News and press releases: Praluent recommended for approval to lower cholesterol

Medicine to offer therapy for patients unable to control high cholesterol with currently available treatment

Europe - EMA - European Medicines Agency

24-7-2015

News and press releases: EMA recommends approval of treatment for attention deficit hyperactivity disorder

Intuniv to be used in combination with comprehensive behavioural treatment in children and adolescents

Europe - EMA - European Medicines Agency

24-7-2015

News and press releases: EMA to review Inductos

The European Medicines Agency (EMA) has started a review of Inductos, an implant used in patients with spinal disc problems and leg fractures.

Europe - EMA - European Medicines Agency

24-7-2015

DG HEALTH ALLERGY (Diphenhydramine Hydrochloride) Tablet [Dolgencorp, LLC]

Updated Date: Jul 24, 2015 EST

US - DailyMed

24-7-2015

LIVIXIL PAK (Lidocaine 2.5% And Prilocaine 2.5%) Kit [Alvix Laboratories, LLC]

Updated Date: Jul 24, 2015 EST

US - DailyMed

24-7-2015

QUETIAPINE FUMARATE Tablet, Film Coated [American Health Packaging]

Updated Date: Jul 24, 2015 EST

US - DailyMed

24-7-2015

CITALOPRAM (Citalopram Hydrobromide) Tablet, Film Coated [American Health Packaging]

Updated Date: Jul 24, 2015 EST

US - DailyMed

24-7-2015

DIVALPROEX SODIUM Capsule, Coated Pellets [American Health Packaging]

Updated Date: Jul 24, 2015 EST

US - DailyMed

24-7-2015

PAIN RELIEVER REGULAR STRENGTH (Acetaminophen) Tablet [WALGREEN CO.]

Updated Date: Jul 24, 2015 EST

US - DailyMed

24-7-2015

CLOPIDOGREL (Clopidogrel Bisulfate) Tablet, Film Coated [American Health Packaging]

Updated Date: Jul 24, 2015 EST

US - DailyMed

24-7-2015

WAL-SLEEP Z (Diphenhydramine Hcl) Tablet, Film Coated [WALGREEN CO.]

Updated Date: Jul 24, 2015 EST

US - DailyMed